Abivax S.A.
ABVX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001956827
No open-market purchases or sales by Abivax S.A. insiders were filed in the last 90 days; 303 institutions reported holding it in 13F filings for Q2 2026, worth $7.18B in total; Maverick Capital is the only superinvestor holding it.
Other share classesAAVXF
13F holders, Q1 2025
Institutional positions in Abivax S.A. as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 46
- −2 vs. Q4 2024
- Shares held
- 31.8M
- +1.90M (+6.4%) vs. Q4 2024
- Total value
- $198.5M
- −$20.1M (−9.2%) vs. Q4 2024
- New holders
- 8
- 18 more added
- Sold out
- 10
- 11 more reduced
Compare with Q4 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ABVX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 303 | $7.18B |
| Q1 2026 | 254 | $5.53B |
| Q4 2025 | 247 | $7.61B |
| Q3 2025 | 165 | $4.41B |
| Q2 2025 | 43 | $234.6M |
| Q1 2025 | 46 | $198.5M |
| Q4 2024 | 48 | $218.6M |
| Q3 2024 | 40 | $312.8M |
| Q2 2024 | 38 | $371.6M |
| Q1 2024 | 36 | $334.2M |
| Q4 2023 | 30 | $227.8M |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2025
Shares, value and share of portfolio for each institution holding Abivax S.A.; share changes are against Q4 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Principal Securities, Inc. | 10 | $73 | 0.00% | 00.0% | Unchanged |
| Financial Management Professionals, Inc. | 100 | $625 | 0.00% | 00.0% | Unchanged |
| Rhumbline Advisers | 738 | $4.61K | 0.00% | +32+4.5% | Added |
| Barclays PLC | 1,478 | $9.24K | 0.00% | +383+35.0% | Added |
| Covestor Ltd | 2,660 | $17.0K | 0.01% | +2,660 | New |
| GAMMA Investing LLC | 3,013 | $18.8K | 0.00% | −963−24.2% | Reduced |
| Hurley Capital, LLC | 3,015 | $18.8K | 0.01% | +3,015 | New |
| Cubist Systematic Strategies, LLC | 10,152 | $63.5K | 0.00% | +2,595+34.3% | Added |
| Bank of America Corp | 10,706 | $66.9K | 0.00% | +5,170+93.4% | Added |
| BNP Paribas Arbitrage, SA | 11,446 | $71.5K | 0.00% | −7,798−40.5% | Reduced |
| Guggenheim Capital LLC | 13,792 | $86.2K | 0.00% | +1,280+10.2% | Added |
| Geode Capital Management, LLC | 16,749 | $104.7K | 0.00% | 00.0% | Unchanged |
| Ameriprise Financial Inc | 19,000 | $118.8K | 0.00% | +7,332+62.8% | Added |
| Point72 Asset Management, L.P. | 29,418 | $183.9K | 0.00% | −61,882−67.8% | Reduced |
| Paloma Partners Management Co | 38,449 | $240.3K | 0.04% | +38,449 | New |
| HighVista Strategies LLC | 49,064 | $306.6K | 0.12% | 00.0% | Unchanged |
| Shay Capital LLC | 52,829 | $330.2K | 0.10% | +2,800+5.6% | Added |
| Marshall Wace, LLP | 74,841 | $467.8K | 0.00% | +74,841 | New |
| Soleus Capital Management, L.P. | 125,000 | $781.3K | 0.06% | 00.0% | Unchanged |
| UBS Group AG | 162,554 | $1.02M | 0.00% | −12,319−7.0% | Reduced |
| Citigroup Inc | 184,239 | $1.15M | 0.00% | +184,239 | New |
| Affinity Asset Advisors, LLC | 200,000 | $1.25M | 0.20% | +200,000 | New |
| Woodline Partners LP | 201,924 | $1.26M | 0.01% | +153,788+319.5% | Added |
| Silverarc Capital Management, LLC | 210,901 | $1.32M | 0.28% | −74,219−26.0% | Reduced |
| Walleye Capital LLC | 220,845 | $1.38M | 0.02% | −81,797−27.0% | Reduced |
| Kennedy Capital Management, Inc. | 225,191 | $1.41M | 0.03% | −279−0.1% | Reduced |
| Samsara BioCapital, LLC | 425,000 | $2.66M | 0.47% | −425,000−50.0% | Reduced |
| Ensign Peak Advisors, Inc | 455,684 | $2.85M | 0.01% | +455,684 | New |
| Morgan Stanley | 497,153 | $3.11M | 0.00% | +17,827+3.7% | Added |
| Saturn V Capital Management LLC | 552,926 | $3.46M | 1.74% | −100,145−15.3% | Reduced |
| Boothbay Fund Management, LLC | 570,668 | $3.57M | 0.13% | +163,765+40.2% | Added |
| Standard Life Aberdeen plc | 710,516 | $4.44M | 0.01% | +286,335+67.5% | Added |
| JPMorgan Chase & Co | 907,679 | $5.67M | 0.00% | +178,760+24.5% | Added |
| Millennium Management LLC | 987,414 | $6.17M | 0.01% | +56,235+6.0% | Added |
| Allostery Investments LP | 1,099,654 | $6.87M | 9.91% | +508,401+86.0% | Added |
| Octagon Capital Advisors LP | 1,230,000 | $7.69M | 1.67% | +1,230,000 | New |
| Caligan Partners LP | 1,269,119 | $7.93M | 1.66% | +516,952+68.7% | Added |
| VR Adviser, LLC | 1,345,780 | $8.41M | 0.72% | 00.0% | Unchanged |
| Franklin Resources Inc | 1,371,050 | $8.57M | 0.00% | −95,012−6.5% | Reduced |
| Citadel Advisors LLC | 1,373,860 | $8.59M | 0.01% | +518,184+60.6% | Added |
| Nantahala Capital Management, LLC | 1,482,994 | $9.27M | 0.77% | +46,947+3.3% | Added |
| Great Point Partners LLC | 1,638,111 | $10.2M | 5.57% | −10,412−0.6% | Reduced |
| Cormorant Asset Management, LP | 2,130,000 | $13.3M | 1.01% | 00.0% | Unchanged |
| ADAR1 Capital Management, LLC | 2,210,019 | $13.8M | 2.66% | +696,626+46.0% | Added |
| Deep Track Capital, LP | 3,579,209 | $22.4M | 0.72% | 00.0% | Unchanged |
| TCG Crossover Management, LLC | 6,056,596 | $37.9M | 5.16% | 00.0% | Unchanged |
| Commodore Capital LP | 0 | $0 | 0.00% | −1,284,110−100.0% | Sold out |
| Blackstone Group Inc. | 0 | $0 | 0.00% | −936,607−100.0% | Sold out |
| Springhill Fund Asset Management (HK) Co Ltd | 0 | $0 | 0.00% | −207,600−100.0% | Sold out |
| Atika Capital Management LLC | 0 | $0 | 0.00% | −103,929−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −19,736−100.0% | Sold out |
| Stonepine Capital Management, LLC | 0 | $0 | 0.00% | −15,000−100.0% | Sold out |
| HighTower Advisors, LLC | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| R Squared Ltd | 0 | $0 | 0.00% | −4,950−100.0% | Sold out |
| Advisor Group Holdings, Inc. | 0 | $0 | 0.00% | −25−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −37−100.0% | Sold out |